Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 241 results for "cipla"

Acquisition is not our strategy: Glenmark chief
Business Standard

Acquisition is not our strategy: Glenmark chief

Recently Lupin and Cipla acquired generic drug companies in the US to expand their presence there BS Reporter | Mumbai September 23, 2015 Last Updated at 00:20 IST Glenn Saldanha Chairman and managing director, Glenmark Glenmark Pharmaceuticals will focus on ... Business Standard, 1 week ago

197 images for cipla

India Infoline, 4 days ago, 5 days ago
NDTV Profit, 1 week ago
NDTV, 1 week ago
Financial Express, 3 weeks ago, 4 weeks ago
Hindu Business Line, 4 weeks ago
Hindu Business Line, 4 weeks ago
Businessworld India, 1 month ago
Times of India, 1 month ago

Broader markets outperform; FMCG, pharma shares weigh

Banks and auto shares gained while FMCG majors ITC and HUL along with pharma majors Cipla, Lupin and Sun Pharma ended lower Tulemino Antao | Mumbai September 21, 2015 Last Updated at 16:02 IST Benchmark share indices ended flat with negative bias on Monday as ...
 Business Standard1 week ago Weakness persists dragged by defensive shares; Nifty holds 7,950  Business Standard1 week ago Sun Pharma leads the pack on NSE, up 3.6%  Business Line1 month ago
Asian Scientist

Cipla Expands Into The US With InvaGen & Exelan Acquistions

Cipla grows its portfolio by acquiring InvaGen and Exelan Pharmaceuticals, stretching its reach to the US market. Asian Scientist Newsroom | September 14, 2015 | Pharma AsianScientist (Sep. 14, 2015) - Cipla EU, the UK arm of ...
 Asian Scientist2 weeks ago Old pharmaceutical companies lag behind newer peers  Economic Times3 weeks ago India's Cipla to Buy Two U.S. Generic Drugmakers  Pharmaceutical Manufacturing Magazine3 weeks ago Cipla up 2%; brokerages bullish, see strong growth momentum  Money Control3 weeks ago
Business Insider India

Another mega pharma deal! Cipla to buy Hyderabad-based Hetero Drugs for $550mn

Cipla is all set to expand its portfolio. And this includes buying of the American business of Hyderabad-based Hetero Drugs. Country's third-largest drug maker will buy Invagen and Camber, Hetero's wholly owned subsidiary, for about $550 million. ...
 Business Insider India1 month ago Cipla set to buy American business of Hetero Drugs for $550 million  Times of India1 month ago Cipla set to buy Hetero's US ops for $550 million  Times of India1 month ago Cipla only Indian company contending for Kremers Urban  DNA1 month ago
Money Today

Cipla shares surge 3% on strong revenue outlook

Shares of Cipla soared nearly 3 per cent in the morning trade trade after the company said it expects 20 per cent growth in revenues in the current fiscal. The shares opened on a bullish note at Rs 673.25 and jumped 2.81 per cent to an early high of Rs ...
 Business Line1 month ago Cipla shares gain on strong revenue outlook  Money Today1 month ago Cipla gains 3 per cent on strong revenue outlook  Business Standard1 month ago Cipla Gains 3% on Strong Outlook for FY16  NDTV Profit1 month ago
Money Control

Cipla gains 3% on strong revenue outlook

The shares opened on a bullish note at Rs 673.25 and jumped 2.81 percent to an early high of Rs 679.75
 Money Control1 month ago Cipla Q1 profit soars over 2-fold to Rs 650.6 cr on exports  Money Control1 month ago Cipla Posts Over Two-Fold Jump in Q1 Profit  NDTV Profit1 month ago Cipla Q1 Profit Rises Over Two-Fold to Rs 651 Cr  NDTV Profit1 month ago
Business Standard India

FIPB to take up 25 FDI proposals on Sep 22

B will take up 25 foreign direct investment (FDI) proposals, including those of Aditya Birla Nuvo, Cipla, Sun Pharma Advanced Research and HDFC Capital Advisors, on September 22. "Meeting of the Foreign Investment Promotion Board (FIPB) is scheduled on ...
 Business Standard3 weeks ago Foreign Investment Promotion Board to take up 25 foreign direct investment proposals on September 22  Economic Times3 weeks ago FIPB clears 18 FDI proposals worth Rs 5,000 cr  Business Standard India5 days ago FIPB clears 18 foreign investment proposals worth Rs 5,000 crore  DNA India5 days ago

Cipla may gain after strong Q1 outcome

On a consolidated basis, Cipla reported 120.9% surge in net profit to Rs 650.61 crore on 41.3% rise in total income to Rs 3901.70 crore in Q1 June 2015 over Q1 June 2014. Cipla's EBITDA rose 91.8% to Rs 1039 crore in Q1 June 2015 over Q1 June 2014. ...
 Business Standard1 month ago Cipla reverses initial gains in volatile trade  Business Standard1 month ago Cipla Q1 net more than doubles to Rs 651 cr  Business Standard1 month ago Cipla Q1 net profit up 120% to Rs651 crore  Livemint.com1 month ago
Businessworld India

Cipla Buys 2 Generic Drug Units In US For Rs 3,655 Crore

The Friday announcement lifted Cipla shares as high as 4 per cent to Rs 675 a unit to start with, the share price settled at 4.4 per cent lower at Rs 652 just before Friday closing, reports C H Unnikrishnan Indian generic drug maker Cipla said on ...
 Businessworld India1 month ago Cipla shares gain on acquisition of 2 US generic firms for $550 million  Financial Express1 month ago

Give bull market another chance; bullish Cipla: Jai Bala

Jai Bala of 1857 Advisors says Bank Nifty's key level will be 15,500. He is bullish on SBI subject to the stock staying above Rs 210 and believes FMCG space to support market, Hindustan Unilever being his top pick.
 Money Control1 month ago Cipla may go above Rs 800: Jai Bala  MSN News US1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less